Neurotrack develops digital cognitive health solutions to reduce the risk of Alzheimer's and related dementias.
Neurotrack is on a mission to transform the diagnosis and prevention of Alzheimer’s and related dementias through its app-based Cognitive Health Program. Its digital cognitive assessments, using groundbreaking eye-tracking technology, are coupled with a personalized intervention program to empower individuals at any age to strengthen their cognitive health through “brain checkups” and targeted lifestyle behaviors. The company was founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola and is based in Redwood City, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2016 | Grant | $800K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |